Evaluation of Interest of LUMEEN Virtual Reality Headset to Reduce Preoperative Anxiety in AMBulatory Surgery
AMBLUMEEN
1 other identifier
interventional
106
1 country
1
Brief Summary
This study evaluate the interest of Virtual Reality to reduce the preoperative anxiety in patients who undergo to ambulatory surgery. Half of the patients will received the virtual reality program, and the other half will received de common treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable anxiety
Started Mar 2023
Shorter than P25 for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 14, 2022
CompletedFirst Posted
Study publicly available on registry
October 21, 2022
CompletedStudy Start
First participant enrolled
March 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 18, 2023
CompletedDecember 22, 2023
December 1, 2023
7 months
October 14, 2022
December 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of Anxiety
Measured by State-Trait Anxiety Inventory (STAI YA) . The scale includes twenty items.. Each question is assigned 1 to 4 points, giving a score of 20 (low anxiety) to 80 points (high anxiety)
D0 : baseline and right before going to surgery
Secondary Outcomes (9)
Number of milligrams of midazolam administered
D0 (before surgery)
Percentage of patients with intraoperative remifentanil required
D0 (during surgery)
Pain score
D0 (after surgery)
Morphine dose used
D0 (after surgery in recovery room)
Perioperative care satisfaction score
through study completion, 1 day
- +4 more secondary outcomes
Study Arms (2)
Control group
OTHERGeneral routine care. This group will undergo to ambulatory surgery without preoperative virtual reality session. Will be applied the usual treatment to reduce preoperative anxiety.
Virtual reality group
EXPERIMENTALVirtual Reality. This group will undergo to 20 min virtual reality before ambulatory surgery. In addition to virtual reality session, will be applied the usual treatment to reduce preoperative anxiety, after virtual reality, if necessary.
Interventions
The 20-minute virtual reality session, in the outpatient department before surgery, immerses the patient in calm environments combined with music therapy and breathing exercises to relax and reduce anxiety.
The State Trait Anxiety Inventory (State anxiety) is a questionnaire given to adults that shows how strong a person's feelings of anxiety are "right now, just now". The score is measured on arrival in the outpatient department and just before going into the intervention room (= after the virtual reality session for the experimental group)
Likert scale satisfaction questionnaire to collect the patients' satisfaction regarding virtual reality session
Likert scale satisfaction questionnaire to collect the patients' satisfaction regarding perioperative care
Eligibility Criteria
You may qualify if:
- ASA I-II (classification of the American Society of Anesthesiologists).
- Ambulatory surgery scheduled
- Score STAI YA \> 45
- Affiliated to a social security
- Understanding the study and signing the informed consent
You may not qualify if:
- Contraindications for Midazolam
- Patients with disorders not compatible with virtual reality: severe cognitive or psychiatric disorders, blindness, claustrophobia, epilepsy
- Patient with a pacemaker of others implantable medical devices
- patient with burns or wounds on the upper face or scalp
- Visual hallucinations
- Contagious disease by air or indirect contact
- Person unable to express their consent
- Minor patient or patient under curatorship or guardianship
- patient participating in another interventional clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Lyon Sud
Pierre-Bénite, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arnaud FRIGGERI
Hospices Civils de Lyon - Centre Hospitalier Lyon Sud
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 14, 2022
First Posted
October 21, 2022
Study Start
March 21, 2023
Primary Completion
October 18, 2023
Study Completion
October 18, 2023
Last Updated
December 22, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share